TY - JOUR
T1 - Genome-wide association reveals contribution of MRAS to painful temporomandibular disorder in males
AU - Smith, Shad B.
AU - Parisien, Marc
AU - Bair, Eric
AU - Belfer, Inna
AU - Chabot-Doré, Anne Julie
AU - Gris, Pavel
AU - Khoury, Samar
AU - Tansley, Shannon
AU - Torosyan, Yelizaveta
AU - Zaykin, Dmitri V.
AU - Bernhardt, Olaf
AU - De Oliveira Serrano, Priscila
AU - Gracely, Richard H.
AU - Jain, Deepti
AU - Järvelin, Marjo Riitta
AU - Kaste, Linda M.
AU - Kerr, Kathleen F.
AU - Kocher, Thomas
AU - Lähdesmäki, Raija
AU - Laniado, Nadia
AU - Laurie, Cathy C.
AU - Laurie, Cecelia A.
AU - Männikkö, Minna
AU - Meloto, Carolina B.
AU - Nackley, Andrea G.
AU - Nelson, Sarah C.
AU - Pesonen, Paula
AU - Ribeiro-Dasilva, Margarete C.
AU - Rizzatti-Barbosa, Celia M.
AU - Sanders, Anne E.
AU - Schwahn, Christian
AU - Sipilä, Kirsi
AU - Sofer, Tamar
AU - Teumer, Alexander
AU - Mogil, Jeffrey S.
AU - Fillingim, Roger B.
AU - Greenspan, Joel D.
AU - Ohrbach, Richard
AU - Slade, Gary D.
AU - Maixner, William
AU - Diatchenko, Luda
N1 - Publisher Copyright:
© 2018 International Association for the Study of Pain.
PY - 2019/3/1
Y1 - 2019/3/1
N2 - Painful temporomandibular disorders (TMDs) are the leading cause of chronic orofacial pain, but its underlying molecular mechanisms remain obscure. Although many environmental factors have been associated with higher risk of developing painful TMD, family and twin studies support a heritable genetic component as well. We performed a genome-wide association study assuming an additive genetic model of TMD in a discovery cohort of 999 cases and 2031 TMD-free controls from the Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) study. Using logistic models adjusted for sex, age, enrollment site, and race, we identified 3 distinct loci that were significant in combined or sex-segregated analyses. A single-nucleotide polymorphism on chromosome 3 (rs13078961) was significantly associated with TMD in males only (odds ratio = 2.9, 95% confidence interval: 2.02-4.27, P = 2.2 × 10-8). This association was nominally replicated in a meta-analysis of 7 independent orofacial pain cohorts including 160,194 participants (odds ratio = 1.16, 95% confidence interval: 1.0-1.35, P = 2.3 × 10-2). Functional analysis in human dorsal root ganglia and blood indicated this variant is an expression quantitative trait locus, with the minor allele associated with decreased expression of the nearby muscle RAS oncogene homolog (MRAS) gene (beta = -0.51, P = 2.43 × 10-5). Male mice, but not female mice, with a null mutation of Mras displayed persistent mechanical allodynia in a model of inflammatory pain. Genetic and behavioral evidence support a novel mechanism by which genetically determined MRAS expression moderates the resiliency to chronic pain. This effect is male-specific and may contribute to the lower rates of painful TMD in men.
AB - Painful temporomandibular disorders (TMDs) are the leading cause of chronic orofacial pain, but its underlying molecular mechanisms remain obscure. Although many environmental factors have been associated with higher risk of developing painful TMD, family and twin studies support a heritable genetic component as well. We performed a genome-wide association study assuming an additive genetic model of TMD in a discovery cohort of 999 cases and 2031 TMD-free controls from the Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) study. Using logistic models adjusted for sex, age, enrollment site, and race, we identified 3 distinct loci that were significant in combined or sex-segregated analyses. A single-nucleotide polymorphism on chromosome 3 (rs13078961) was significantly associated with TMD in males only (odds ratio = 2.9, 95% confidence interval: 2.02-4.27, P = 2.2 × 10-8). This association was nominally replicated in a meta-analysis of 7 independent orofacial pain cohorts including 160,194 participants (odds ratio = 1.16, 95% confidence interval: 1.0-1.35, P = 2.3 × 10-2). Functional analysis in human dorsal root ganglia and blood indicated this variant is an expression quantitative trait locus, with the minor allele associated with decreased expression of the nearby muscle RAS oncogene homolog (MRAS) gene (beta = -0.51, P = 2.43 × 10-5). Male mice, but not female mice, with a null mutation of Mras displayed persistent mechanical allodynia in a model of inflammatory pain. Genetic and behavioral evidence support a novel mechanism by which genetically determined MRAS expression moderates the resiliency to chronic pain. This effect is male-specific and may contribute to the lower rates of painful TMD in men.
KW - Bioinformatics
KW - Chronic pain
KW - Expression quantitative trait locus
KW - Genome-wide association study
KW - Meta-analysis
KW - Temporomandibular joint disease
UR - https://www.scopus.com/pages/publications/85061610268
U2 - 10.1097/j.pain.0000000000001438
DO - 10.1097/j.pain.0000000000001438
M3 - Article
C2 - 30431558
AN - SCOPUS:85061610268
SN - 0304-3959
VL - 160
SP - 579
EP - 591
JO - Pain
JF - Pain
IS - 3
ER -